Mobile health behaviour change support system as independent treatment tool for obesity: a randomized controlled trial
Markkanen, Jaakko O.; Oikarinen, Noora; Savolainen, Markku J.; Merikallio, Heta; Nyman, Ville; Salminen, Ville; Virkkula, Teppo; Karppinen, Pasi; Oinas-Kukkonen, Harri; Hukkanen, Janne (2023-12-07)
Markkanen, Jaakko O.
Oikarinen, Noora
Savolainen, Markku J.
Merikallio, Heta
Nyman, Ville
Salminen, Ville
Virkkula, Teppo
Karppinen, Pasi
Oinas-Kukkonen, Harri
Hukkanen, Janne
Springer
07.12.2023
Markkanen, J.O., Oikarinen, N., Savolainen, M.J. et al. Mobile health behaviour change support system as independent treatment tool for obesity: a randomized controlled trial. Int J Obes 48, 376–383 (2024). https://doi.org/10.1038/s41366-023-01426-x
https://creativecommons.org/licenses/by/4.0/
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
https://creativecommons.org/licenses/by/4.0/
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
https://creativecommons.org/licenses/by/4.0/
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:oulu-202401091143
https://urn.fi/URN:NBN:fi:oulu-202401091143
Tiivistelmä
Abstract
Background/Objectives:
Digital health interventions are increasingly utilized as an adjunct to face-to-face counselling in the treatment of obesity. However, previous studies have shown inconsistent efficacy when digital interventions are used as stand-alone treatment. The purpose of this study was to investigate whether a mobile health behaviour change support system (mHBCSS) is effective in weight reduction and weight loss maintenance without additional counselling. Furthermore, changes in cardiometabolic risk factors were investigated.
Methods:
In this randomized controlled trial, a mHBCSS intervention was conducted for 200 volunteers with obesity (BMI 30–40 kg/m² and age 18–65 years). The study participants were randomly assigned into two groups: immediate access to mHBCSS intervention or wait-list control with access to mHBCSS after 6 months. Anthropometric and metabolic traits were also measured. The primary outcome was weight loss from the baseline to the 6-month visit.
Results:
Among 200 participants (88.5% women), mean BMI (SD) was 34.3 kg/m² (2.8) and age 46.5 years (9.5). The retention rate was 98.5% and 89.0% at the 6- and 12-month visits, respectively. At the 6-month visit, those with immediate access to mHBCSS had significantly greater weight loss (−2.5%, 95% CI −3.4 to −1.6, p < 0.001) compared with the wait-list control group (0.2%, 95% CI –0.4 to 0.9, p = 0.466; between groups p < 0.001). Weight loss was maintained until the 12-month time point in the mHBCSS group (−2.1%, 95% CI −3.3 to −0.9, p = 0.001). The usage of mHBCSS had no significant effect on metabolic traits.
Conclusion:
The mHBCSS as a stand-alone treatment of obesity results in weight reduction and weight loss maintenance with remarkable adherence rate. Further studies are needed to establish how to best implement the scalable and resource-efficient mHBCSS into the standard care of obesity to achieve optimal weight loss results.
Background/Objectives:
Digital health interventions are increasingly utilized as an adjunct to face-to-face counselling in the treatment of obesity. However, previous studies have shown inconsistent efficacy when digital interventions are used as stand-alone treatment. The purpose of this study was to investigate whether a mobile health behaviour change support system (mHBCSS) is effective in weight reduction and weight loss maintenance without additional counselling. Furthermore, changes in cardiometabolic risk factors were investigated.
Methods:
In this randomized controlled trial, a mHBCSS intervention was conducted for 200 volunteers with obesity (BMI 30–40 kg/m² and age 18–65 years). The study participants were randomly assigned into two groups: immediate access to mHBCSS intervention or wait-list control with access to mHBCSS after 6 months. Anthropometric and metabolic traits were also measured. The primary outcome was weight loss from the baseline to the 6-month visit.
Results:
Among 200 participants (88.5% women), mean BMI (SD) was 34.3 kg/m² (2.8) and age 46.5 years (9.5). The retention rate was 98.5% and 89.0% at the 6- and 12-month visits, respectively. At the 6-month visit, those with immediate access to mHBCSS had significantly greater weight loss (−2.5%, 95% CI −3.4 to −1.6, p < 0.001) compared with the wait-list control group (0.2%, 95% CI –0.4 to 0.9, p = 0.466; between groups p < 0.001). Weight loss was maintained until the 12-month time point in the mHBCSS group (−2.1%, 95% CI −3.3 to −0.9, p = 0.001). The usage of mHBCSS had no significant effect on metabolic traits.
Conclusion:
The mHBCSS as a stand-alone treatment of obesity results in weight reduction and weight loss maintenance with remarkable adherence rate. Further studies are needed to establish how to best implement the scalable and resource-efficient mHBCSS into the standard care of obesity to achieve optimal weight loss results.
Kokoelmat
- Avoin saatavuus [41242]

